163 related articles for article (PubMed ID: 6785399)
1. Measurement of 24-hour whole-body retention of Tc-99m HEDP by a gamma camera.
Martin W; Fogelman I; Bessent RG
J Nucl Med; 1981 Jun; 22(6):542-5. PubMed ID: 6785399
[TBL] [Abstract][Full Text] [Related]
2. [Quantitative whole-body skeletal scintigraphy with a gamma camera and pinhole collimator].
Anger K; Köhnen H; Stockberg H; Traut A; Winandi R
Nuklearmedizin; 1985 Feb; 24(1):2-6. PubMed ID: 3158885
[TBL] [Abstract][Full Text] [Related]
3. A comparison of skeletal uptakes of three diphosphonates by whole-body retention: concise communication.
Fogelman I; Pearson DW; Bessent RG; Tofe AJ; Francis MD
J Nucl Med; 1981 Oct; 22(10):880-3. PubMed ID: 6457135
[TBL] [Abstract][Full Text] [Related]
4. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. I. Synthesis and distribution in animals.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):961-6. PubMed ID: 6252298
[TBL] [Abstract][Full Text] [Related]
5. Skeletal uptake of Tc-99m HEDP in primary hyperparathyroidism.
Fogelman I; Greig WR; Bessent RG; Boyle IT
J Nucl Med; 1977 Oct; 18(10):1040-1. PubMed ID: 409748
[No Abstract] [Full Text] [Related]
6. Accuracy of 24-h whole-body (skeletal) retention of diphosphonate measurements.
Fogelman I; Bessent R; Scullion JE; Cuthbert GF
Eur J Nucl Med; 1982; 7(8):359-63. PubMed ID: 6811274
[No Abstract] [Full Text] [Related]
7. Relative distribution of diphosphonate between bone and soft tissue at 4 and 24 hours: concise communication.
Smith ML; Martin W; Fogelman I; Bessent RG
J Nucl Med; 1983 Mar; 24(3):208-11. PubMed ID: 6402571
[TBL] [Abstract][Full Text] [Related]
8. Tc-99m HMDP (hydroxymethylene diphosphonate): a radiopharmaceutical for skeletal and acute myocardial infarct imaging. II. Comparison of Tc-99m hydroxymethylene diphosphonate (HMDP) with other technetium-labeled bone-imaging agents in a canine model.
Bevan JA; Tofe AJ; Benedict JJ; Francis MD; Barnett BL
J Nucl Med; 1980 Oct; 21(10):967-70. PubMed ID: 6252299
[TBL] [Abstract][Full Text] [Related]
9. Whole body and regional retention of Tc-99m-labeled diphosphonates with a whole-body counter: a study with normal males.
Molloi S; Mazess R; Bendsen H; Wilson M
Calcif Tissue Int; 1989 May; 44(5):322-9. PubMed ID: 2496903
[TBL] [Abstract][Full Text] [Related]
10. Measurement of 24-hour whole-body retention of Tc-99mMDP with a thyroid uptake probe: quantitative assessment of metabolic and metastatic bone diseases.
Seto H; Futatsuya R; Ihara F; Kamei T; Furumoto N; Ishizaki Y; Hada M; Kakishita M
Radiat Med; 1984; 2(2):87-92. PubMed ID: 6240671
[TBL] [Abstract][Full Text] [Related]
11. Diphosphonates in the evaluation of metabolic bone disease.
Fogelman I; Smith ML
Clin Rheumatol; 1982 Mar; 1(1):41-4. PubMed ID: 6236012
[TBL] [Abstract][Full Text] [Related]
12. Bone uptake studies in rabbits before and after high-dose treatment with 153Sm-EDTMP or 186Re-HEDP.
Brenner W; Kampen WU; Brümmer C; von Forstner C; Zuhayra M; Czech N; Muhle C; Henze E
J Nucl Med; 2003 Feb; 44(2):247-51. PubMed ID: 12571217
[TBL] [Abstract][Full Text] [Related]
13. 99mTc-diphosphonate whole-body retention measurements using a conic-beam collimator and a scintillation detector.
Vattimo A
J Nucl Med Allied Sci; 1987; 31(3):291-4. PubMed ID: 3121810
[No Abstract] [Full Text] [Related]
14. Comparative evaluation of three diphosphonates: in vitro adsorption (C- 14 labeled) and in vivo osteogenic uptake (Tc-99m complexed).
Francis MD; Ferguson DL; Tofe AJ; Bevan JA; Michaels SE
J Nucl Med; 1980 Dec; 21(12):1185-9. PubMed ID: 6449567
[TBL] [Abstract][Full Text] [Related]
15. 24 hour whole body retention of 99mTc-methylene-diphosphonate in the assessment of bone formation. Methodological evaluation, clinical applications and comparison with serum alkaline phosphatase and serum osteocalcin.
Hyldstrup L
Dan Med Bull; 1989 Sep; 36(4):349-58. PubMed ID: 2509145
[No Abstract] [Full Text] [Related]
16. Quantitative studies of bone using (99m)Tc-methylene diphosphonate skeletal plasma clearance.
Blake GM; Moore AE; Fogelman I
Semin Nucl Med; 2009 Nov; 39(6):369-79. PubMed ID: 19801217
[TBL] [Abstract][Full Text] [Related]
17. In vivo distributions of some component fractions of Tc(NaBH4)-HEDP mixtures separated by anion exchange high performance liquid chromatography.
Pinkerton TC; Ferguson DL; Deutsch E; Heineman WR; Libson K
Int J Appl Radiat Isot; 1982 Oct; 33(10):907-15. PubMed ID: 6818160
[TBL] [Abstract][Full Text] [Related]
18. Measurements of the distribution of technetium-99m sulfur colloid and technetium-99m HEDP in normal humans.
Grossman LW; Sodd VJ; Nishiyama H; Feller PA; Hoops RG
Med Phys; 1983; 10(1):79-82. PubMed ID: 6405144
[TBL] [Abstract][Full Text] [Related]
19. Age-related alterations in skeletal metabolism--24-hr whole-body retention of diphosphonate in 250 normal subjects: concise communication.
Fogelman I; Bessent R
J Nucl Med; 1982 Apr; 23(4):296-300. PubMed ID: 6802938
[TBL] [Abstract][Full Text] [Related]
20. The use of whole-body retention of Tc-99m diphosphonate in the diagnosis of metabolic bone disease.
Fogelman I; Bessent RG; Turner JG; Citrin DL; Boyle IT; Greig WR
J Nucl Med; 1978 Mar; 19(3):270-5. PubMed ID: 564941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]